April 2011
Volume 52, Issue 14
ARVO Annual Meeting Abstract  |   April 2011
In Vivo Characterization of Inflammatory Cell Recruitment into the Ocular Surface Following Exposure to Benzalkonium Chloride
Author Affiliations & Notes
  • Jose Echegaray
    Bascom Palmer Eye Institute, University of Miami, Miami, Florida
  • Michelle Senchyna
    Alcon Research, LTD, Fort Worth, Texas
  • David Meadows
    Alcon Research, LTD, Fort Worth, Texas
  • Howard A. Ketelson
    Alcon Research, LTD, Fort Worth, Texas
  • Victor L. Perez
    Bascom Palmer Eye Institute, University of Miami, Miami, Florida
  • Footnotes
    Commercial Relationships  Jose Echegaray, None; Michelle Senchyna, None; David Meadows, None; Howard A. Ketelson, None; Victor L. Perez, Alcon (F, C, R)
  • Footnotes
    Support  30 EY014801 NIH, Research for Prevent Blindness, and Alcon Research, LTD
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 1129. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jose Echegaray, Michelle Senchyna, David Meadows, Howard A. Ketelson, Victor L. Perez; In Vivo Characterization of Inflammatory Cell Recruitment into the Ocular Surface Following Exposure to Benzalkonium Chloride. Invest. Ophthalmol. Vis. Sci. 2011;52(14):1129.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To determine the dose - response relationship between benzalkonium chloride (BAC ) topically applied to the ocular surface and the induction of a corneal inflammatory response as quantified by in vivo intravital fluorescence stereomicroscopy.

Methods: : Recruitment of inflammatory cells was monitored by in vivo fluorescent microscopy and digital photography in Enhanced Green Protein Fluorescently labeled (EGFP) chimeric mice. One eye of each EGFP mouse was topically dosed with a single drop (5µL) of BAC (0.005, 0.01, 0.02, 0.05, 0.1, 0.2 %wt/%vl), where as the contra lateral eye was dosed with saline (control eye). Dosing occurred at days 0, 3, 5, 7, 10 and 15 while under short term anesthesia. In vivo recruitment of EGFP cells was captured at days 1, 3, 5, 7, 10, 15 and 25 and quantification of EGFP cell migration was performed using pixel analysis on digital photos using Image Pro. Corneal haze and scarring was qualitatively evaluated at similar time points.

Results: : Recruitment of EGFP labeled inflammatory cells was detected in BAC treated corneas with concentrations between 0.05% and 0.2% as early as day 3 and continued to increase in magnitude over the course of the dosing period. This was significantly different from control eyes (p-value <0.001). Similarly, mice treated with lower doses (0.005% to 0.02 %), also displayed significant inflammatory cell recruitment into the cornea, however, the tempo was slower and was not observed until day 10 of treatment (p-value <0.001). In both groups, the magnitude of EGFP cell corneal infiltration correlated with the degree of corneal haze and scarring.

Conclusions: : Data demonstrate that ocular surface exposure to BAC induces an inflammatory response in a dose - dependent fashion with respect to both tempo and magnitude. Importantly, lower doses of BAC also stimulate the recruitment of inflammatory cells confirming the potentially damaging effects associated with this preservative. This model will help identify the inflammatory signals involved in this process and enable the development of alternative preservatives for use in ophthalmic products.

Keywords: inflammation • cornea: stroma and keratocytes • image processing 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.